<a href="https://www.medchemexpress.com/EPZ-5676.html">EPZ-5676</a>产品描述:EPZ-5676 is a potent and selective aminonucleoside inhibitor of <b>DOT1L histone methyltransferase</b> with <b>K<sub>i</sub></b> of < 80 pM, demonstrating > 37,000-fold selectivity against all other PMTs tested, and inhibits H3K79 methylation in tumor. IC50 & Target: Ki: < 80 pM (DOT1L histone methyltransferase) <i><b>In Vitro:</b></i> EPZ-5676 inhibits H3K79me2 with IC<sub>50</sub> values of 3 nM and 5 nM in MV4-11 and HL60 cells, respectively. EPZ-5676 is a potent inhibitor of MV4-11 proliferation with an IC<sub>50</sub> value of 3.5 nM<sup>[1]</sup>. EPZ-5676 induces a synergistic and durable antiproliferative effect, increases expression of differentiation markers and apoptosis as dingle agent, and demonstrates combination benefit in combination with AML standard of care drugs in MLL-r cells<sup>[2]</sup>.<i><b>In Vivo:</b></i> EPZ-5676 (70 mg/kg, i.p.) causes complete and sustained regression in a rat xenograft model of MLL-rearranged leukemia. EPZ-5676 (70, 35 mg/kg, i.v.)<br><br><br><span style="outline: 0.0px;line-height: 22.0px;color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;background-color: rgb(251,251,251);">公司介绍:MedChemExpress(MCE)专注于各种抑制剂、激动剂、API及化合物库,总部位于美国新泽西,分别在瑞典和上海设有欧洲区子公司和亚洲区总代理,营销网点遍及全球20多个国家地区。MCE经过多年努力已成为全球生物活性小分子领域的一流供应商, 产品涵盖癌症、神经科学、抗感染、表观遗传学等20个热门研究领域,PI3K、MAPK等近千个细分靶点,超过4000个活性小分子化合物现货,以及GPCR、API、离子通道等超过20种不同类型的化合物库,同时提供从毫克到千克的专业定制合成服务。</span><br style="color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;line-height: 22.0px;background-color: rgb(251,251,251);"><span style="outline: 0.0px;line-height: 22.0px;color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;background-color: rgb(251,251,251);">MCE 对每批产品都进行严格的LCMS和NMR检验,其产品已被全球近万名客户广泛使用并发表大量文章、专利;</span><br style="color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;line-height: 22.0px;background-color: rgb(251,251,251);"><span style="outline: 0.0px;line-height: 22.0px;color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;background-color: rgb(251,251,251);">MCE 定期增加各领域热门抑制剂、激动剂,不断扩增已有化合物库,以满足最新的科研需求;</span><br style="color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;line-height: 22.0px;background-color: rgb(251,251,251);"><span style="outline: 0.0px;line-height: 22.0px;color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;background-color: rgb(251,251,251);">数千种产品在上海有充足备货,24-48小时内送达客户;</span><br style="color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;line-height: 22.0px;background-color: rgb(251,251,251);"><span style="outline: 0.0px;line-height: 22.0px;color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;background-color: rgb(251,251,251);">大量产品提供免费试用装;</span><span style="outline: 0.0px;line-height: 22.0px;color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;background-color: rgb(251,251,251);">已为全球多个知名企业、院校构建各种定制型化合物库。</span><br><br>产品链接:<a href="http://www.medchemexpress.cn/epz-5676.html">www.medchemexpress.cn/epz-5676.html</a><br><br></span><img style="width: 600.0px;height: 310.0px;" src="http://img.dxycdn.com/trademd/upload/userfiles/image/2014/08/A1408605159png_small.jpg" alt=""> |
EPZ-5676研究进展
发布日期:2017-10-31 浏览次数:0
核心提示:a href=https://www.medchemexpress.com/EPZ-5676.htmlEPZ-5676/a产品描述:EPZ-5676 is a potent and selective aminonucleosid
- 下一篇:暂无
- 上一篇:2(3H)-Furanone, 3-[[3,5-bis(1,
行业动态
更多...
- EPZ-5676研究进展 10-31
- 2(3H)-Furanone, 3-[[3,5- 10-30
- Imoxiterol研究进展 10-30
- NEO 376研究进展 10-30
- ZT 52656A (hydrochloride 10-30
- Bucloxic acid研究进展 10-30
- Paliroden研究进展 10-30
- LY 178002研究进展 10-30
- 2614W94研究进展 10-30
- NCX899研究进展 10-30